Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioFortis Introduces Next Generation Biobanking Software Platform

Published: Monday, September 24, 2012
Last Updated: Sunday, September 23, 2012
Bookmark and Share
Helps organizations involved in biomarker-based clinical and translational research to safely and effectively conduct externalized, science-driven collaborative studies.

BioFortis Inc. has introduced its Next Generation Biobanking software platform for biomarker-based clinical research.

It will help pharmaceutical, government and academic research centers involved in biomarker-based clinical and translational studies to safely and effectively conduct externalized, science-driven collaborative studies.

As biomarker-based clinical research has become more commonplace, organizations have looked to biobanks to help drive these studies.

However, this approach poses significant challenges to conventional biobanks and their software.

The Next Generation Biobanking software platform is designed to overcome these challenges by harmonizing biospecimen data with clinical and molecular data in a collaborative environment that emphasizes scientific insights, while ensuring security and compliance.

At the core of the Next Generation Biobanking software solution is the Labmatrix® platform.

Labmatrix goes beyond the sample-centric workflows of conventional biobanking software by integrating patient, clinical, specimen, genetic and molecular assay data, to deliver holistic views of studies.

Multi-level user access control ensures that all collaborators can work effectively while maintaining relevant privacy and regulatory compliance objectives.

Driving scientific insights is one of the key benefits of Next Generation Biobanking software. Mining the wealth of data across studies, searching for the patterns within, and discovering knowledge requires tools that augment the user's own expertise.

To meet that need, the Next Generation Biobanking software platform provides Qiagram®, the award-winning visual ad hoc query tool.

Qiagram puts powerful query and knowledge discovery tools in the hands of the individual researcher.

Users "draw" their questions, interactively creating sophisticated queries, without the need to program or struggle with complicated query builders.

Answers are presented in configurable visualizations and dashboard widgets that can be shared to generate cross-study, cross-site and cross-group knowledge.

"Based on experiences with many pharmaceutical companies and academic centers, we believe that our Next Generation Biobanking software bridges the gap between conventional biobanking software and the needs of biomarker-based clinical research," commented BioFortis CEO, Jian Wang, PhD, "We consider it critical to empower researchers to perform these kinds of studies and deliver safer and effective clinical outcomes."

The BioFortis Next Generation Biobanking software platform will be demonstrated at Booth #226 at the 2012 Clinical Business Expo, September 19-20, Boston, MA.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!